| Year |
Citation |
Score |
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Rossing MA, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35314806 DOI: 10.1038/s41431-022-01085-y |
0.427 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Rossing MA, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.499 |
|
| 2021 |
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, ... ... Rossing MA, et al. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789471 DOI: 10.1158/1055-9965.EPI-21-0977 |
0.455 |
|
| 2020 |
Lee AW, Rosenzweig S, Wiensch A, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, ... ... Rossing MA, et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. Journal of the National Cancer Institute. PMID 32766851 DOI: 10.1093/Jnci/Djaa099 |
0.6 |
|
| 2020 |
Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, ... ... Rossing MA, et al. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecologic Oncology. PMID 32641237 DOI: 10.1016/J.Ygyno.2020.06.481 |
0.469 |
|
| 2020 |
Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, Leong HS, Chen S, Intermaggio MP, Gilks B, Nazeran TM, Volchek M, Elatre W, Bentley RC, ... ... Rossing MA, et al. Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32554541 DOI: 10.1158/1078-0432.Ccr-20-0103 |
0.355 |
|
| 2020 |
Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, ... Rossing MA, et al. Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics. PMID 32546565 DOI: 10.1136/Jmedgenet-2019-106739 |
0.531 |
|
| 2020 |
Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, Chen S, Elatre W, Gilks B, Nazeran T, Volchek M, Bentley RC, Wang C, Chiu DS, ... ... Rossing MA, et al. Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32473302 DOI: 10.1016/J.Annonc.2020.05.019 |
0.427 |
|
| 2020 |
Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, Harris HR, Rossing MA, Doherty JA, Fortner RT, Chang-Claude J, Goodman MT, Thompson PJ, Moysich KB, Ness RB, et al. Association Between Breastfeeding and Ovarian Cancer Risk. Jama Oncology. e200421. PMID 32239218 DOI: 10.1001/Jamaoncol.2020.0421 |
0.603 |
|
| 2020 |
Lee AW, Wu AH, Wiensch A, Mukherjee B, Terry KL, Harris HR, Carney ME, Jensen A, Cramer DW, Berchuck A, Doherty JA, Modugno F, Goodman MT, Alimujiang A, Rossing MA, et al. Estrogen plus progestin hormone therapy and ovarian cancer: a complicated relationship explored. Epidemiology (Cambridge, Mass.). PMID 32028322 DOI: 10.1097/Ede.0000000000001175 |
0.509 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Rossing MA, et al. Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 4386. PMID 31548585 DOI: 10.1038/S41467-019-12095-8 |
0.393 |
|
| 2019 |
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/Ije/Dyz113 |
0.547 |
|
| 2019 |
Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, ... ... Rossing MA, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Medicine. PMID 31001917 DOI: 10.1002/Cam4.1996 |
0.46 |
|
| 2019 |
Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, ... ... Rossing MA, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. PMID 30905014 DOI: 10.1007/S10552-019-01157-3 |
0.491 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Rossing MA, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.513 |
|
| 2019 |
Sasamoto N, Babic A, Jordan S, Risch H, Harris H, Rossing MA, Doherty J, Goodman M, Thompson P, Kjær SK, Jensen A, Schildkraut J, Titus L, Cramer D, Bandera E, et al. Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-640 |
0.595 |
|
| 2018 |
Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, ... ... Rossing MA, et al. A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants. International Journal of Cancer. PMID 30499236 DOI: 10.1002/Ijc.32029 |
0.569 |
|
| 2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.452 |
|
| 2018 |
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, ... ... Rossing MA, et al. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research. PMID 30054336 DOI: 10.1158/0008-5472.Can-18-0951 |
0.494 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Rossing MA, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.544 |
|
| 2018 |
Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. Journal of the National Cancer Institute. PMID 29718305 DOI: 10.1093/Jnci/Djy071 |
0.509 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... Rossing MA, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.59 |
|
| 2017 |
Ugai T, Kelemen LE, Mizuno M, Ong JS, Webb PM, Chenevix-Trench G, Wicklund KG, Doherty JA, Rossing MA, Thompson PJ, Wilkens LR, Carney ME, Goodman MT, Schildkraut JM, et al. Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. Cancer Science. PMID 29247577 DOI: 10.1111/Cas.13470 |
0.494 |
|
| 2017 |
Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... ... Rossing MA, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29211900 DOI: 10.1093/ije/dyx252 |
0.464 |
|
| 2017 |
Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.Epi-17-0655 |
0.598 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, ... ... Rossing MA, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1470-1473. PMID 28864456 DOI: 10.1158/1055-9965.Epi-17-0367 |
0.525 |
|
| 2017 |
Babic A, Harris HR, Vitonis AF, Titus LJ, Jordan SJ, Webb PM, Risch HA, Rossing MA, Doherty JA, Wicklund K, Goodman MT, Modugno F, Moysich KB, Ness R, et al. Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium. International Journal of Cancer. PMID 28833087 DOI: 10.1002/Ijc.31010 |
0.39 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, ... ... Rossing MA, et al. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. British Journal of Cancer. PMID 28817835 DOI: 10.1038/Bjc.2017.267 |
0.504 |
|
| 2017 |
Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P, Chang-Claude J, Conti DV, Ann Doherty J, ... ... Rossing MA, et al. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. International Journal of Cancer. PMID 28699174 DOI: 10.1002/Ijc.30883 |
0.511 |
|
| 2017 |
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/Bjc.2017.68 |
0.527 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, ... ... Rossing MA, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer Causes & Control : Ccc. PMID 28293802 DOI: 10.1007/S10552-017-0867-1 |
0.502 |
|
| 2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... ... Rossing MA, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.551 |
|
| 2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.468 |
|
| 2017 |
Harris HR, Jordan S, Risch H, Rossing MA, Goodman MT, Modugno F, Kjær SK, Schildkraut JM, Bandera EV, Wentzensen N, Phelan C, Anton-Culver H, Wu AH, Terry KL. Abstract 2293: Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium Cancer Research. 77: 2293-2293. DOI: 10.1158/1538-7445.Am2017-2293 |
0.613 |
|
| 2016 |
Reid BM, Permuth JB, Chen YA, Teer JK, Monteiro AN, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA, Goode EL, Iverson ES, Lawrenson K, ... ... Rossing MA, et al. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28035019 DOI: 10.1158/1055-9965.EPI-16-0341 |
0.401 |
|
| 2016 |
Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/Aje/Kww161 |
0.594 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.455 |
|
| 2016 |
Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 |
0.396 |
|
| 2016 |
Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, Wallace PK, ... ... Rossing MA, et al. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27677730 DOI: 10.1158/1055-9965.Epi-16-0631 |
0.459 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... ... Rossing MA, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.441 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Rossing MA, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.431 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Rossing MA, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.49 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Rossing MA, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.579 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal of Cancer. PMID 27420401 DOI: 10.1002/Ijc.30274 |
0.59 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.566 |
|
| 2016 |
Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, ... ... Rossing MA, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 |
0.489 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Rossing MA, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.556 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Rossing MA, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.575 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.406 |
|
| 2016 |
Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, ... ... Rossing MA, et al. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and Gynecology. PMID 27054934 DOI: 10.1097/01.Ogx.0000489579.62561.B8 |
0.418 |
|
| 2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... ... Rossing MA, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.45 |
|
| 2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.467 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Rossing MA, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.534 |
|
| 2016 |
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Rossing MA, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 |
0.437 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Rossing MA, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.56 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Cancer Research. 76: 797-797. DOI: 10.1158/1538-7445.Am2016-797 |
0.564 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli G, Bandera EV, Berchuck A, ... ... Rossing MA, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium Obstetrical and Gynecological Survey. 71: 528-530. DOI: 10.1097/Ogx.0000000000000357 |
0.554 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Rossing MA, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.529 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Rossing MA, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.383 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Rossing MA, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.414 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Rossing MA, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.514 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Rossing MA, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.523 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Rossing MA, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.538 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Rossing MA, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.519 |
|
| 2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.529 |
|
| 2015 |
Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, ... ... Rossing MA, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 26151456 DOI: 10.1038/Bjc.2015.245 |
0.535 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Rossing MA, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.539 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Rossing MA, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.563 |
|
| 2015 |
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 671-6. PMID 25623732 DOI: 10.1158/1055-9965.Epi-14-1128 |
0.544 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Rossing MA, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.426 |
|
| 2015 |
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Rossing MA, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 |
0.488 |
|
| 2015 |
Permuth-Wey J, Reid BM, Chen YA, Lin H, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode E, Iversen E, Pearce L, Pharoah PDP, Phelan C, ... ... Rossing MA, et al. Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility Cancer Research. 75: 4635-4635. DOI: 10.1158/1538-7445.Am2015-4635 |
0.503 |
|
| 2015 |
Reid BM, Permuth-Wey J, Chen YA, Lin H, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode EL, Iversen E, Pearce L, Pharoah P, Phelan C, ... ... Rossing MA, et al. Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk Cancer Research. 75: 4634-4634. DOI: 10.1158/1538-7445.Am2015-4634 |
0.539 |
|
| 2015 |
Sellers TA, Reid BM, Chen YA, Lin H, Richards E, Teer J, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Goode E, Iverson E, Pearce L, Pharoah P, ... ... Rossing MA, et al. Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk Cancer Research. 75: 4633-4633. DOI: 10.1158/1538-7445.Am2015-4633 |
0.486 |
|
| 2014 |
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 |
0.371 |
|
| 2014 |
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, ... ... Rossing MA, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136 |
0.525 |
|
| 2014 |
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962 |
0.456 |
|
| 2014 |
Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. Journal of the National Cancer Institute. 106: djt431. PMID 24503200 DOI: 10.1093/Jnci/Djt431 |
0.532 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Rossing MA, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.62 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Rossing MA, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.544 |
|
| 2013 |
Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, ... ... Rossing MA, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research (Philadelphia, Pa.). 6: 811-21. PMID 23761272 DOI: 10.1158/1940-6207.Capr-13-0037 |
0.588 |
|
| 2013 |
Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology. 42: 579-89. PMID 23569193 DOI: 10.1093/Ije/Dyt042 |
0.596 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Rossing MA, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.537 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Rossing MA, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.509 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Rossing MA, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.591 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Rossing MA, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.371 |
|
| 2013 |
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 987-92. PMID 23513043 DOI: 10.1158/1055-9965.Epi-13-0028 |
0.567 |
|
| 2013 |
Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 880-90. PMID 23462924 DOI: 10.1158/1055-9965.Epi-12-1030-T |
0.532 |
|
| 2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.531 |
|
| 2013 |
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395 |
0.616 |
|
| 2013 |
Bhatti P, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. Nightshift work and risk of ovarian cancer. Occupational and Environmental Medicine. 70: 231-7. PMID 23343856 DOI: 10.1136/Oemed-2012-101146 |
0.566 |
|
| 2013 |
Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Köbel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, et al. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium. Bmc Cancer. 13: 28. PMID 23339562 DOI: 10.1186/1471-2407-13-28 |
0.486 |
|
| 2012 |
Bodelon C, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. Sun exposure and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 23: 1985-94. PMID 23065074 DOI: 10.1007/S10552-012-0076-X |
0.517 |
|
| 2012 |
Phipps AI, Scoggins J, Rossing MA, Li CI, Newcomb PA. Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007. American Journal of Public Health. 102: 1791-7. PMID 22873481 DOI: 10.2105/Ajph.2011.300393 |
0.382 |
|
| 2012 |
Beral V, Hermon C, Peto R, Reeves G, Brinton L, Marchbanks P, Negri E, Ness R, Peeters PHM, Vessey M, Calle EE, Gapstur SM, Patel AV, Maso LD, Talamini R, ... ... Rossing MA, et al. Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies Plos Medicine. 9. PMID 22606070 DOI: 10.1371/Journal.Pmed.1001200 |
0.537 |
|
| 2012 |
Jordan SJ, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. Breast-feeding and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 23: 919-27. PMID 22527170 DOI: 10.1007/S10552-012-9963-4 |
0.49 |
|
| 2012 |
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet. Oncology. 13: 385-94. PMID 22361336 DOI: 10.1016/S1470-2045(11)70404-1 |
0.617 |
|
| 2011 |
Phipps AI, Doherty JA, Voigt LF, Hill DA, Beresford SA, Rossing MA, Chen C, Weiss NS. Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer. Cancer Causes & Control : Ccc. 22: 1639-46. PMID 21909949 DOI: 10.1007/S10552-011-9840-6 |
0.526 |
|
| 2011 |
Doherty JA, Weiss NS, Fish S, Fan W, Loomis MM, Sakoda LC, Rossing MA, Zhao LP, Chen C. Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1873-82. PMID 21750170 DOI: 10.1158/1055-9965.Epi-11-0119 |
0.55 |
|
| 2011 |
Pocobelli G, Doherty JA, Voigt LF, Beresford SA, Hill DA, Chen C, Rossing MA, Holmes RS, Noor ZS, Weiss NS. Pregnancy history and risk of endometrial cancer. Epidemiology (Cambridge, Mass.). 22: 638-45. PMID 21691206 DOI: 10.1097/Ede.0B013E3182263018 |
0.502 |
|
| 2011 |
Rosenblatt KA, Weiss NS, Cushing-Haugen KL, Wicklund KG, Rossing MA. Genital powder exposure and the risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 22: 737-42. PMID 21516319 DOI: 10.1007/S10552-011-9746-3 |
0.548 |
|
| 2011 |
Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prevention Research (Philadelphia, Pa.). 4: 840-50. PMID 21505180 DOI: 10.1158/1940-6207.Capr-10-0389 |
0.457 |
|
| 2011 |
Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, ... ... Rossing MA, et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics. 20: 2263-72. PMID 21422097 DOI: 10.1093/Hmg/Ddr087 |
0.626 |
|
| 2011 |
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, ... ... Rossing MA, et al. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1028-31. PMID 21415361 DOI: 10.1158/1055-9965.Epi-11-0053 |
0.547 |
|
| 2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Rossing MA, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.602 |
|
| 2011 |
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, et al. Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertility and Sterility. 95: 40-5. PMID 20719308 DOI: 10.1016/J.Fertnstert.2010.06.059 |
0.38 |
|
| 2011 |
Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, ... ... Rossing MA, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 128: 2063-74. PMID 20635389 DOI: 10.1002/Ijc.25554 |
0.581 |
|
| 2011 |
Doherty JA, Weiss NS, Fish S, Fan W, Loomis MM, Rossing MA, Zhao LP, Chen C. Abstract 5620: Polymorphisms in steroid hormone genes and endometrial cancer risk Cancer Research. 71: 5620-5620. DOI: 10.1158/1538-7445.Am2011-5620 |
0.601 |
|
| 2010 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Rossing MA, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 |
0.518 |
|
| 2010 |
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Rossing MA, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 |
0.516 |
|
| 2010 |
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". Plos Genetics. 6: e1001016. PMID 20628624 DOI: 10.1371/Journal.Pgen.1001016 |
0.587 |
|
| 2010 |
Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G, et al. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1822-30. PMID 20570913 DOI: 10.1158/1055-9965.Epi-09-1317 |
0.489 |
|
| 2010 |
Littman AJ, Tang MT, Rossing MA. Longitudinal study of recreational physical activity in breast cancer survivors. Journal of Cancer Survivorship : Research and Practice. 4: 119-27. PMID 20180037 DOI: 10.1007/S11764-009-0113-2 |
0.435 |
|
| 2010 |
Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, ... ... Rossing MA, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 |
0.613 |
|
| 2010 |
Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS. Predictive value of symptoms for early detection of ovarian cancer. Journal of the National Cancer Institute. 102: 222-9. PMID 20110551 DOI: 10.1093/Jnci/Djp500 |
0.351 |
|
| 2010 |
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 245-50. PMID 20056644 DOI: 10.1158/1055-9965.Epi-09-0729 |
0.594 |
|
| 2010 |
Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Recreational physical activity and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 21: 485-91. PMID 19953315 DOI: 10.1007/S10552-009-9479-8 |
0.549 |
|
| 2010 |
Doherty JA, Weiss NS, Fish S, Loomis MM, Rossing MA, Chen C. Abstract LB-415: Polymorphisms in nucleotide excision repair genes and endometrial cancer risk Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-415 |
0.579 |
|
| 2009 |
Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS. Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. American Journal of Epidemiology. 170: 1512-7. PMID 19897512 DOI: 10.1093/Aje/Kwp321 |
0.583 |
|
| 2009 |
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... ... Rossing MA, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424 |
0.567 |
|
| 2009 |
Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM, Goode EL, Rider DN, Vierkant RA, Anderson S, Wu AH, Pike M, Van Den Berg D, ... ... Rossing MA, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 12: 269-75. PMID 19456219 DOI: 10.1375/Twin.12.3.269 |
0.6 |
|
| 2009 |
McTiernan A, Wang CY, Sorensen B, Xiao L, Buist DSM, Aiello Bowles EJ, White E, Rossing MA, Potter J, Urban N. No effect of aspirin on mammographic density in a randomized controlled clinical trial Cancer Epidemiology Biomarkers and Prevention. 18: 1524-1530. PMID 19423529 DOI: 10.1158/1055-9965.Epi-08-1088 |
0.401 |
|
| 2009 |
Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, ... ... Rossing MA, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138 |
0.634 |
|
| 2009 |
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947 |
0.548 |
|
| 2009 |
Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, ... ... Rossing MA, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer. 100: 412-20. PMID 19127255 DOI: 10.1038/Sj.Bjc.6604820 |
0.773 |
|
| 2008 |
Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, ... ... Rossing MA, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3567-72. PMID 19064572 DOI: 10.1158/1055-9965.Epi-08-0548 |
0.591 |
|
| 2008 |
Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes & Control : Ccc. 19: 1357-64. PMID 18704718 DOI: 10.1007/S10552-008-9207-9 |
0.489 |
|
| 2008 |
Hannibal CG, Rossing MA, Wicklund KG, Cushing-Haugen KL. Analgesic drug use and risk of epithelial ovarian cancer. American Journal of Epidemiology. 167: 1430-7. PMID 18390840 DOI: 10.1093/Aje/Kwn082 |
0.544 |
|
| 2008 |
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 712-6. PMID 18349292 DOI: 10.1158/1055-9965.Epi-07-2511 |
0.627 |
|
| 2008 |
Rossing MA, Cushing-Haugen KL, Doherty JA, Wicklund KG. Characteristics related to the maternal intrauterine environment and risk of epithelial ovarian cancer. Annals of Epidemiology. 18: 411-5. PMID 18261928 DOI: 10.1016/J.Annepidem.2007.11.015 |
0.572 |
|
| 2008 |
Rossing MA, Cushing-Haugen KL, Wicklund KG, Weiss NS. Cigarette smoking and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 19: 413-20. PMID 18080774 DOI: 10.1007/S10552-007-9103-8 |
0.464 |
|
| 2008 |
Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Research and Treatment. 112: 123-32. PMID 18058227 DOI: 10.1007/S10549-007-9828-9 |
0.491 |
|
| 2007 |
Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2548-56. PMID 18086757 DOI: 10.1158/1055-9965.Epi-07-0550 |
0.486 |
|
| 2007 |
Holt SK, Rossing MA, Malone KE, Schwartz SM, Weiss NS, Chen C. Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 481-9. PMID 17372243 DOI: 10.1093/Aje/163.Suppl_11.S253-C |
0.782 |
|
| 2007 |
Ton TG, Rossing MA, Bowen DJ, Wilkerson HW, Farin FM. Cholecystokinin C-45T polymorphism and smoking cessation in women Nicotine and Tobacco Research. 9: 147-151. PMID 17365745 DOI: 10.1080/14622200601078301 |
0.307 |
|
| 2007 |
Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Research : Bcr. 9: R6. PMID 17239243 DOI: 10.1186/Bcr1639 |
0.434 |
|
| 2007 |
Ton TG, Heckbert SR, Longstreth WT, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. Calcium channel blockers and beta-blockers in relation to Parkinson's disease. Parkinsonism & Related Disorders. 13: 165-9. PMID 17055323 DOI: 10.1016/J.Parkreldis.2006.08.011 |
0.307 |
|
| 2006 |
Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG, Weiss NS. Body size and risk of epithelial ovarian cancer (United States). Cancer Causes & Control : Ccc. 17: 713-20. PMID 16633919 DOI: 10.1007/S10552-006-0010-1 |
0.453 |
|
| 2006 |
Ton TG, Heckbert SR, Longstreth WT, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 964-9. PMID 16550541 DOI: 10.1002/Mds.20856 |
0.335 |
|
| 2006 |
Fulton-Kehoe D, Rossing MA, Rutter C, Mandelson MT, Weiss NS. Use of antidepressant medications in relation to the incidence of breast cancer. British Journal of Cancer. 94: 1071-8. PMID 16523201 DOI: 10.1038/Sj.Bjc.6603017 |
0.716 |
|
| 2006 |
Ton TG, Rossing MA, Bowen DJ, Farin FM. Genetic Polymorphisms in Dopamine-Related Genes and Smoking Cessation in Women American Journal of Epidemiology. 163. DOI: 10.1093/Aje/163.Suppl_11.S130-B |
0.302 |
|
| 2005 |
Doherty JA, Weiss NS, Freeman RJ, Dightman DA, Thornton PJ, Houck JR, Voigt LF, Rossing MA, Schwartz SM, Chen C. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 357-66. PMID 15734958 DOI: 10.1158/1055-9965.Epi-04-0479 |
0.563 |
|
| 2004 |
Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. American Journal of Epidemiology. 160: 1070-8. PMID 15561986 DOI: 10.1093/Aje/Kwh315 |
0.559 |
|
| 2003 |
Littman AJ, Rossing MA, Madeleine MM, Tang MT, Yasui Y. Association between late age at infectious mononucleosis, Epstein-Barr virus antibodies, and ovarian cancer risk. Scandinavian Journal of Infectious Diseases. 35: 728-35. PMID 14606612 DOI: 10.1080/00365540310016556 |
0.54 |
|
| 2003 |
Littman AJ, Rossing MA, Madeleine MM, Tang MC, Yasui Y. Age at infectious mononucleosis and ovarian cancer risk Annals of Epidemiology. 13: 578-579. DOI: 10.1016/S1047-2797(03)00190-X |
0.544 |
|
| 2002 |
Dublin S, Rossing MA, Heckbert SR, Goff BA, Weiss NS. Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications. Cancer Causes & Control : Ccc. 13: 35-45. PMID 11899116 DOI: 10.1023/A:1013969611593 |
0.567 |
|
| 2001 |
Rossing MA, Remler R, Voigt LF, Wicklund KG, Daling JR. Recreational physical activity and risk of papillary thyroid cancer (United States). Cancer Causes & Control : Ccc. 12: 881-5. PMID 11808706 DOI: 10.1023/A:1013757030600 |
0.54 |
|
| 2001 |
Lambe M, Rossing MA, Wuu J, Hsieh C. Breast cancer risk in women who have had children with different partners. International Journal of Cancer. 93: 907-10. PMID 11519056 DOI: 10.1002/Ijc.1414 |
0.508 |
|
| 2001 |
Weiss NS, Rossing MA. Oestrogen-replacement therapy and risk of ovarian cancer. Lancet (London, England). 358: 438. PMID 11513905 DOI: 10.1016/S0140-6736(01)05669-0 |
0.53 |
|
| 2001 |
O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. Journal of the National Cancer Institute. 93: 754-62. PMID 11353785 DOI: 10.1093/Jnci/93.10.754 |
0.434 |
|
| 2001 |
Weiss NS, Rossing MA. Non-hormonal contraception and the risk of ovarian cancer. Epidemiology (Cambridge, Mass.). 12: 300. PMID 11337602 DOI: 10.1097/00001648-200105000-00008 |
0.572 |
|
| 2001 |
Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J. Breast cancer risk and "delayed" primary Epstein-Barr virus infection Cancer Epidemiology Biomarkers and Prevention. 10: 9-16. PMID 11205495 |
0.323 |
|
| 2000 |
Li CI, Rossing MA, Voigt LF, Daling JR. Multiple primary breast and thyroid cancers: Role of age at diagnosis and cancer treatments (United States) Cancer Causes and Control. 11: 805-811. PMID 11075869 DOI: 10.1023/A:1008942616092 |
0.563 |
|
| 2000 |
Martin KM, Rossing MA, Ryland LM, DiGiacomo RE, Freitag WA. Evaluation of dietary and environmental risk factors for hyperthyroidism in cats Journal of the American Veterinary Medical Association. 217: 853-856. PMID 10997155 DOI: 10.2460/Javma.2000.217.853 |
0.348 |
|
| 2000 |
Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women American Journal of Epidemiology. 151: 765-772. PMID 10965973 DOI: 10.1093/Oxfordjournals.Aje.A010276 |
0.431 |
|
| 2000 |
Rossing MA, Scholes D, Cushing-Haugen KL, Voigt LF. Cimetidine use and risk of prostate and breast cancer Cancer Epidemiology Biomarkers and Prevention. 9: 319-323. PMID 10750671 |
0.429 |
|
| 2000 |
Mockett EJ, Rossing MA, Weiss NS. Fetal antigen hypothesis and ovarian cancer: Is there an immunogenic explanation for the reduction in risk associated with parity? Epidemiology. 11: 55-58. PMID 10615844 DOI: 10.1097/00001648-200001000-00012 |
0.545 |
|
| 2000 |
Rossing MA, Cushing KL, Voigt LF, Wicklund KG, Daling JR. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption Epidemiology. 11: 49-54. PMID 10615843 DOI: 10.1097/00001648-200001000-00011 |
0.437 |
|
| 1999 |
Rossing MA, Daling JR. Complexity of surveillance for cancer risk associated with in-vitro fertilisation Lancet. 354: 1573-1574. PMID 10560666 DOI: 10.1016/S0140-6736(99)90309-4 |
0.545 |
|
| 1999 |
Wittenberg L, Cook LS, Rossing MA, Weiss NS. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer Epidemiology. 10: 761-763. PMID 10535792 |
0.493 |
|
| 1999 |
Lambe M, Wuu J, Rossing MA, Hsieh CC. Twinning and maternal risk of ovarian cancer Lancet. 353: 1941. PMID 10371582 DOI: 10.1016/S0140-6736(99)02000-0 |
0.479 |
|
| 1999 |
Satia JA, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL, Rossing MA. Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica International Journal of Cancer. 82: 28-32. PMID 10360816 DOI: 10.1002/(Sici)1097-0215(19990702)82:1<28::Aid-Ijc6>3.0.Co;2-X |
0.324 |
|
| 1998 |
Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR. Use of exogenous hormones and risk of papillary thyroid cancer (Washington, United States) Cancer Causes and Control. 9: 341-349. PMID 9684714 DOI: 10.1023/A:1008833422577 |
0.547 |
|
| 1998 |
Weiss HA, Troisi R, Rossing MA, Brogan D, Coates RJ, Gammon MD, Potischman N, Swanson CA, Brinton LA. Fertility problems and breast cancer risk in young women: a case-control study in the United States. Cancer Causes & Control : Ccc. 9: 331-9. PMID 9684713 DOI: 10.1023/A:1008881305738 |
0.517 |
|
| 1997 |
Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Annals of Surgery. 225: 69-75. PMID 8998122 DOI: 10.1097/00000658-199701000-00008 |
0.438 |
|
| 1996 |
Weiss NS, Rossing MA. Healthy Screenee Bias in Epidemiologic Studies of Cancer Incidence Epidemiology. 7: 319-322. PMID 8728451 |
0.399 |
|
| 1996 |
Rossing MA, Stanford JL, Weiss NS, Daling JR. Indices of exposure to fetal and sperm antigens in relation to the occurrence of breast cancer Epidemiology. 7: 309-311. PMID 8728448 DOI: 10.1097/00001648-199605000-00017 |
0.512 |
|
| 1996 |
Rossing MA, Stanford JL, Weiss NS, Habel LA. Oral contraceptive use and risk of breast cancer in middle-aged women American Journal of Epidemiology. 144: 161-164. PMID 8678047 DOI: 10.1093/Oxfordjournals.Aje.A008903 |
0.507 |
|
| 1996 |
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort of infertile women Gynecologic Oncology. 60: 3-7. PMID 8557223 DOI: 10.1006/Gyno.1996.0002 |
0.545 |
|
| 1996 |
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. In situ and invasive cervical carcinoma in a cohort of infertile women Fertility and Sterility. 65: 19-22. PMID 8557140 DOI: 10.1016/S0015-0282(16)58021-2 |
0.5 |
|
| 1996 |
Rossing MA. Ovarian cancer: A risk of infertility treatment? Journal of the British Fertility Society. 1: 46-50. |
0.446 |
|
| 1995 |
Rossing MA, Schwartz SM, Weiss NS. Thyroid cancer incidence in Asian migrants to the United States and their descendants Cancer Causes and Control. 6: 439-444. PMID 8547542 DOI: 10.1007/Bf00052184 |
0.534 |
|
| 1995 |
Habel LA, Stanford JL, Vaughan TL, Rossing MA, Voigt LF, Weiss NS, Daling JR. Occupation and breast cancer risk in middle-aged women Journal of Occupational and Environmental Medicine. 37: 349-356. PMID 7796203 DOI: 10.1097/00043764-199503000-00012 |
0.511 |
|
| 1995 |
Del Priore G, Robischon K, Phipps WR, Kurman R, Wallach EE, Zacur HA, Shapiro S, Rossing MA, Daling JR, Weiss NS, Cramer DW, Hartge P, Nasca PC, Whittemore AS. Risk of ovarian cancer after treatment for infertility [1] New England Journal of Medicine. 332: 1300-1302. PMID 7772146 DOI: 10.1056/NEJM199505113321912 |
0.473 |
|
| 1995 |
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of cutaneous melanoma in a cohort of infertile women Melanoma Research. 5: 123-127. PMID 7620340 DOI: 10.1097/00008390-199504000-00009 |
0.466 |
|
| 1995 |
Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women Journal of the American Medical Association. 274: 137-142. PMID 7596001 DOI: 10.1001/Jama.1995.03530020055032 |
0.537 |
|
| 1995 |
Rossing MA, Weiss N, Vecchia CL, Negri E, Parazzini F, Franceschi S. Fertility drugs and breast and ovarian cancer The Lancet. 346: 1627-1628. PMID 7500767 DOI: 10.1016/S0140-6736(95)91960-0 |
0.449 |
|
| 1994 |
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women New England Journal of Medicine. 331: 771-776. PMID 8065405 DOI: 10.1097/00006254-199502000-00022 |
0.469 |
|
| 1994 |
Basuki B, Rossing MA, Daling JR. Intrauterine device use and risk of tubal pregnancy: An Indonesian case-control study International Journal of Epidemiology. 23: 1000-1005. PMID 7860150 DOI: 10.1093/Ije/23.5.1000 |
0.385 |
|
| 1993 |
Rossing MA, Daling JR, Weiss NS, Voigt LF, Stergachis AS, Wang SP, Grayston JT. Past use of an intrauterine device and risk of tubal pregnancy Epidemiology. 4: 245-251. PMID 8512988 DOI: 10.1097/00001648-199305000-00008 |
0.381 |
|
| 1991 |
Brunskill AJ, Rossing MA, Connell FA, Daling J. Antecedents of macrosomia Paediatric and Perinatal Epidemiology. 5: 392-401. PMID 1754498 DOI: 10.1111/J.1365-3016.1991.Tb00725.X |
0.353 |
|
| 1989 |
Rossing MA, Vaughan TL, McKnight B. Diet and pharyngeal cancer International Journal of Cancer. 44: 593-597. PMID 2793230 DOI: 10.1002/Ijc.2910440406 |
0.436 |
|
| Show low-probability matches. |